Liver transplantation is now the accepted treatment for patients with endstage chronic liver disease. The continuing improvement in patient survival is due to several factors, including better selection, improvement in operative techniques, and a greater understanding of postoperative management. In most centres indications for liver replacement include disease symptoms resulting in an intolerable quality of life for the patient or an estimated survival in the absence of transplantation of one year or less. The National Institutes of Health Consensus Development Conference of 1983 stated that 'an ideally timed liver transplant would be in a late enough phase of the disease to offer the patient no opportunity for spontaneous stabilization or recovery but in an early enough phase to give the surgical procedure a fair chance of success."
Primary biliary cirrhosis is the commonest indication for liver transplantation in the United Kingdom. The natural history of the disease is well understood and various prognostic factors have been defined. Serum levels of hyaluronic acid and procollagen-3-peptide have been reported to correlate with survival,2 3 patients with primary biliary cirrhosis were referred to this hospital specifically for consideration of liver replacement. There were seven men and 100 women, with a median age of 51 years (range 33-68 years). In all cases the diagnosis was confirmed by the presence of antimitochondrial antibodies and compatible histology. One patient was accepted for transplantation because of intractable pruritus, and the remainder were selected if the estimated survival based on clinical assessment was six months or less. Altogether, 29% of the patients were referred from various liver units and 62% from district general hospitals. The remainder were either patients who were being followed up here or who were referred from abroad.3 During the time studied the proportion of patients from different types of centres remained constant.
The prognostic index (PI) for each patient at the time of referral for possible transplantation (or at the time when transplantation was first considered in the case of local patients) was calculated. (PI=2-52 x log bilirubin+0 0069 x exp((age in years-20)/10)-0 05xalbumin+ 0-88 ifcirrhotic+0 68 ifcentral cholestasis+0 52 if not treated with azathioprine.) The PI was transformed to give estimated median survival times, a PI of 6 implying a median estimated survival of nine months and a PI of 5 about two years.' STATISTICS Kendall rank correlation analysis was used to analyse the relation between date of referral and serum bilirubin concentration or PI. Cox regression analysis was used to relate survival after transplantation to either PI or serum bilirubin concentration. 
Results
The numbers of patients with primary biliary cirrhosis referred each year for transplantation has increased since the expansion of the liver transplant programme. The outcome for the patients is shown in Figure 1 . Eighty two of the 107 patients were accepted for transplantation, 63 within six months of the original referral; 19 patients were initially deferred (median interval between referral and acceptance 10 months).
Seventy (85%) of the 82 patients received a liver graft four days-25 months (median three months) after referral. Eight patients died while on the waiting list for a transplant; six of these patients had been referred at a very late stage in their disease with an estimated survival of two months or less. Four patients remain on the waiting list. Seven patients were not accepted for a transplant, five because they were considered too ill to withstand surgery at the time of referral and two because they had contraindications (lymphocytic leukaemia and severe pulmonary disease). Four patients declined the offer of a transplant, and 14 patients are currently being followed up.
REFERRAL PATTERN WITH TIME
The median serum bilirubin concentration at the time of referral was 230 ,tmol/l (range [tmol/l) and the median PI was [6] [7] [8] One year posttransplant survival in p with a PI at referral greater than 7 2 (i estimated survival time without transpla <4 months) was approximately 50%, v patients with a PI of less than 6-0 at the referral (median estimated survival time v transplantation >9 months) had an over year survival of 78% after transplan Patients in the middle tertile (PI betweer 7 2) had a one year actuarial surviva grafting of 63% (Fig 3A) .
Patients were also divided into tertiles ing to the serum bilirubin concentratiom time of referral. Patients with a concentra <188 iimol/l and those with 188-335 at referral had one month survivals of 8( 82% respectively. Patients with a concen of >335 ,umol/l had a one month surv 68%. The one year actuarial survivals wex 63%, and 45% for the high, middle, au bilirubin groups (Fig 3B) . at the time of referral the median estimated survival time was 4-6 months, implying that at ere due Birmingham we are referred patients at a much (one), later stage in their illness. Secondly, the present on the analysis is looking at outcome as predicted by as they bilirubin concentration at referral rather than at n. One the time of transplantation. Finally, the Pittsrgery at burgh group, using a prognostic model derived ent was in the Mayo Clinic,6 found that those with a monary worse prognosis at the time of transplantation did less well after grafting.'0 Serum bilirubin )atients concentration is also a major component of their median model. It appears, therefore, that in patients who ntation are at a less advanced stage of their disease at vhereas referral, or at grafting, serum bilirubin concentime of tration may be a less important prognostic factor vithout for survival after grafting. rall one
The greatest concern is that despite the itation. increasing awareness of liver transplantation, a 6 and many patients are still being referred at such a l after late stage of the disease that the chances of a successful outcome are greatly prejudiced. Only accord-36% of patients in this series were referred with a s at the serum bilirubin concentration of less than 170 ition of iimol/l, which Shapiro and colleagues found to ,tmol/l be associated with an estimated survival in the )% and absence of grafting of 17 months.4 Retrospective tration analysis has not shown any evidence that there is rival of even a small trend towards earlier referral.
re 75%, It is appreciated that the optimal time for liver nd low grafting in primary biliary cirrhosis is not always easy to determine. Many centres are currently reporting one year survival rates of about 80%, thus the timing of the procedure must be one of balance; early grafting is associated with better survival but incurs the risk of shortening the patient's life if the procedure is unsuccessful. On the other hand, late grafting is associated with a higher postoperative mortality. It must also be remembered that the quality of life of the patient in the last stages of liver disease is likely to be poor, with many side effects such as extreme lethargy and pruritus. The natural history of primary biliary cirrhosis is relatively well understood, but death can also be unpredictable due to events such as variceal haemorrhage or sepsis. Indeed,, transplantation may be considered for indications other than endstage disease: these may include intractable lethargy or pruritus, encephalopathy, or repeated variceal haemorrhage. When considering patients for transplantation, the serum bilirubin concentration may be a more useful guide for referral than an estimate of survival. Our own analysis" has shown that the prognostic factors for survival with primary biliary cirrhosis are different to those which predict survival after transplantation. This observation accounts for the findings that the serum bilirubin concentration more closely correlates with survival after grafting than the PI.
Some have advocated referral to a transplant centre when the serum bilirubin concentration reaches 100 ,umol/l.'2 In this centre it is felt that grafting should be considered before it reaches 150 [tmol/l. Earlier referral not only allows the transplant centre time to assess the patients, but perhaps equally importantly the patients are able to assess the centre, meet patients who have undergone liver transplantation, and evaluate for themselves the risks and benefits of such a major procedure.
If patients with primary biliary cirrhosis are to receive optimal treatment, with transplantation being carried out when the chances of survival are greatest, it is essential that patients are referred at an early enough stage of the disease for this to be achieved. It is hoped that the increasing numbers of patients being referred and improving survival figures from the transplant centres will give referring physicians greater confidence to do this.
We are greatly indebted to all the medical, surgical, nursing, and other staff who have contributed to the care of these patients and also to Susan Paris of the Liver Unit Database. cirrhosis for liver transplantation.
